Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Colitis, Ulcerative; september 14, 2023 Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Colitis, Ulcerative; Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Colitis, Ulcerative;Crohn Disease, Date of authorisation: 22/05/2014, Revision: 25, Status: Authorised Lees verder » Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief. Delen Link ophalen Facebook X Pinterest E-mail Andere apps Delen Link ophalen Facebook X Pinterest E-mail Andere apps